You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 1, January 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Newborn Screening for Sickling Hemoglobinopathies

Houston, 1976 to 1980

Robert L. Nussbaum, MD; Carolyn Powell, RN; Herman L. Graham, MT; C. Thomas Caskey, MD; Donald J. Fernbach, MD

Am J Dis Child. 1984;138(1):44-48.


Abstract

• Fifty of 52 infants with cord blood hemoglobin electrophoresis patterns indicative of a possible sickling hemoglobinopathy (SH) were followed up prospectively. A retrospective group of 39 children whose mothers were contacted two to four years after the birth of a child with a positive newborn screening test formed a comparison group. During an average follow-up period of 30 months, children of mothers who were informed early of a positive cord blood test were hospitalized more readily for complications of an SH. During this same period, five (6%) of 88 infants with fetal and sickle hemoglobin (FS) or fetal, sickle, and C hemoglobins (FSC) in their cord blood died, all before 6 months of age. All five deaths occurred in infants whose parents were unaware of their child's disease; four of the five deaths may have been caused by sepsis. These results alone did not prove that screening significantly reduces mortality but did show that newborn screening increases parental awareness of complications and may, therefore, improve the prognosis in sickle cell disease in infancy.

(AJDC 1984;138:44-48)



Author Affiliations

From the Howard Hughes Medical Institute (Drs Nussbaum and Caskey), the Departments of Medicine (Drs Nussbaum and Caskey and Ms Powell) and Pediatrics (Dr Fernbach), Baylor College of Medicine, and the Research Hematology Laboratory, Texas Children's Hospital (Mr Graham), Houston.


Footnotes

Read in part before the meeting of the American Society of Human Genetics, Dallas, Oct 31, 1981.

Reprint requests to Department of Medicine, Baylor College of Medicine, 1200 Moursund, Houston, TX 77030 (Dr Nussbaum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Newborn screening for sickle cell disease in the Republic of Benin
Rahimy et al.
J. Clin. Pathol. 2009;62:46-48.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.